Abstract:
Background: Diabetic kidney disease is one of the complications of diabetes mellitus. It occurs in 20–40%
of patients with diabetes and is associated with significant additional health expenditure. Despite the
increasing prevalence of diabetes mellitus there is inadequate data regarding prevalence of diabetic kidney
disease and its associated factors in West Shoa, Ethiopia.
Objective: To assess the prevalence of diabetic kidney disease and associated factors among type-1 and
type-2 diabetic patients on follow at Ambo university referral hospital medical referral clinic during a
period of 06months (from August 7, 2023 G.C to February 8, 2024 G.C).
Method: Institution based cross sectional study was conducted among type 1- and type-2 diabetic patients
on follow up at Ambo university referral hospital. A total of 130 participants were selected using simple
random sampling technique. Data was collected by interviewer administered questionnaire. Serum
creatinine and albuminuria were determined twice, on two different occasions, each 03months apart. The
data collected was entered into computer and analyzed using statistical package for social science (SPSS)
version 26. Means, standard deviations and percentages were computed and simple binary logistic
regression model was used to calculate odd ratios (ORs) with 95% confidence interval (CI) to assess
various variable relationships. A P value of 0.05 was used to determine statistical significance.
Result: The prevalence of diabetic kidney disease was found to be 9.2% (95% CI: 9.15% - 9.24%). Of all
the participants, 6(4.65%) had reduced estimated glomerular filtration rate (EGFR <60 ml/min/2.73m2) and
8(6.2%) had albuminuria (+1 or above).Those who were not taking statin (AOR: 10.502, 95% CI: 2.238
49.285)had higher chance while never smokers(AOR: 0.027, 95% CI: 0.002-0.325) and those without
metabolic syndrome (AOR: 0.028, 95% CI: 0.002-0.429) had lower chance of diabetic kidney disease.
Conclusion: The study showed that the prevalence of diabetic kidney disease is lower than previous studies.
It also showed that use of statin, having no history of smoking and absence metabolic syndrome decreases
the likelihood of developing diabetic kidney disease among diabetic patients
